Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples